ArticleThe protein journal2023

Development of a Chimeric Protein BiPPB-mIFNγ-tTβRII for Improving the Anti-Fibrotic Activity in Vivo by Targeting Fibrotic Liver and Dual Inhibiting the TGF-β1/Smad Signaling Pathway.

Yixin Dong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.